The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

 
Web www.patentalert.com

< Compositions and methods for promoting angiogenesis

> Bronchodilating beta-agonist compositions and methods

~ 00482